Drug intelligence / Profile preview

Klosterfrau Baldrian 1200

Development stage
Unknown
Lead developer
MCM Klosterfrau
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Klosterfrau Baldrian 1200 is a dietary supplement developed by MCM Klosterfrau to support restful sleep and promote relaxation. It is formulated as an oral tablet containing a high-dose valerian root extract (equivalent to 1,200 mg of valerian root) combined with B vitamins, including riboflavin (vitamin B2), pyridoxine (vitamin B6), and nicotinamide (niacin). These B vitamins contribute to the normal functioning of the nervous system. The product is marketed in Germany and other European countries for individuals experiencing sleep disturbances, inner restlessness, or nervous tension.

Brand names
Klosterfrau BaldrianKlosterfrau Baldrian 1200Klosterfrau Baldrian 1200 Tabletten
Other names
valerian root extract + riboflavin + pyridoxine + nicotinamidevalerian root extract + vitamin B2 + vitamin B6 + niacin
02

Targets

ABAT (4-aminobutyrate aminotransferase)HTR5A (Serotonin Receptor 5A)ADORA1 (Adenosine receptor A1 subtype)GABRB2 (GABA-A receptor subunit beta-2)GABRB3 (GABA-A receptor subunit beta-3)

Beyond the preview

Go deeper on Klosterfrau Baldrian 1200.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Klosterfrau Baldrian 1200.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call